3 completed, 1 active not recruiting, 1 recruiting. 5 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Active not recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow NMO Spectrum Disorder: new trials by email Literature Review of NMO Spectrum Disorder trials Research Report on NMO Spectrum Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases BAFF-R CART - Chronic Inflammatory Demyelinating Polyradiculoneuropathy, NMO Spectrum Disorder | Phase 1 / Phase 2 | Recruiting | Tianjin Medical University General Hospital | 27 | 2025-04-10 | 2026-10-16 |
| Efficacy and Safety of Baricitinib in Neuromyelitis Optica Spectrum Disorders Baricitinib - NMO Spectrum Disorder | Phase 1 | Active not recruiting | Tianjin Medical University General Hospital | 11 | 2023-04-15 | 2026-08-11 |
| A Study of LP-168 in Healthy Volunteers LP-168 tablet, LP-168 Placebo tablet - Multiple Sclerosis, NMO Spectrum Disorder | Phase 1 | Completed | Guangzhou Lupeng Pharmaceutical Company LTD. | 70 | 2022-05-14 | 2023-02-24 |
| Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders Belimumab - NMO Spectrum Disorder | Phase 1 / Phase 2 | Completed | Tianjin Medical University General Hospital | 14 | 2021-12-12 | 2024-10-16 |
| A Study of HBM9161 in NMOSD Patients HBM9161 Injection - NMO Spectrum Disorder | Phase 1 | Completed | Harbour BioMed (Guangzhou) Co. Ltd. | 9 | 2020-03-31 | 2022-01-25 |
Neuromyelitis Optica (5) · Multiple Sclerosis (1) · Myasthenia Gravis (1) · Myositis (1) · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (1)
Autoimmune Diseases (5) · Autoimmune Diseases of the Nervous System (5) · Cranial Nerve Diseases (5) · Demyelinating Autoimmune Diseases, CNS (5) · Demyelinating Diseases (5) · Eye Diseases (5) · Immune System Diseases (5) · Myelitis, Transverse (5) · Nervous System Diseases (5) · Optic Nerve Diseases (5) · Optic Neuritis (5) · Chronic Disease (1) · Disease Attributes (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1)
HBM9161 (1) · baricitinib (1) · belimumab (1)
Tianjin Medical University General Hospital (3) · Guangzhou Lupeng Pharmaceutical Company LTD. (1) · Harbour BioMed (Guangzhou) Co. Ltd. (1)
China (5)
Jinliang Chen, PhD (1) · Qiang Liu, M.D.,Ph.D (1) · Qiang Liu, M.D.,PhD (1) · Wei Qiu (1)